Liver Cancer Rates Are Rising. Do You Know the Treatable Risk Factors?

Several health issues tied to liver disease can be managed or treated before they lead to cirrhosis or cancer. A Michigan Medicine liver specialist explains the connection.

7:00 AM

Author | Rene Wisely

Liver cancer diagnoses have more than tripled in the United States since 1980.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

The culprit? A perfect storm of treatable factors, one Michigan Medicine specialist says.

The prevalence of hepatitis C in baby boomers as well as spiking rates of obesity, diabetes and high cholesterol among all ages — is responsible, says Neehar Parikh, M.D., M.S., a clinical lecturer and medical director of the University of Michigan Comprehensive Cancer Center's Liver Tumor Program.

Many boomers don't know they have hepatitis C because screenings of donated blood and organs were not available until 1992.

And a rise in the latter health conditions, Parikh notes, is linked to an uptick in nonalcoholic fatty liver disease, or NAFLD, an accumulation of excess fat in the liver.

"These two trends have come to a head in the United States, so we're seeing more liver cancer as a result," he says.

Fortunately, hepatitis C and NAFLD have promising outcomes if caught early, before they can advance to cirrhosis or liver cancer.

Silent risks of liver disease

Hepatitis C is a curable virus that spreads when people share blood through the use of infected needles to inject illicit drugs, during sex or, although rare, during childbirth.

It kills more people in the United States than any other infectious disease, according to the Centers for Disease Control and Prevention.

But because symptoms seldom emerge in hepatitis C and NAFLD, patients may go undiagnosed for several decades. By then, scarring of the liver or cirrhosis may have occurred, which can lead to complications including liver cancer. Meanwhile, Parikh's recent research has found that as the nation's obesity rates rise, the number of patients with NAFLD-related liver disease and liver cancer is increasing rapidly.

Prevention of chronic liver disease: lifesaving knowledge

The two main types of liver cancer, in which the cancer begins in the liver cells themselves rather than spreading to the liver, are hepatocellular carcinoma (also called hepatoma, or HCC) and bile duct cancer, or cholangiocarcinoma.

SEE ALSO: How to Have a Healthy Liver

"These are highly morbid cancers we're talking about," Parikh says.

But, he adds, they don't have to be: "Awareness about the underlying conditions is the key."

That requires patients to be proactive.

"Ask for a hepatitis C screening from your primary care doctor if you are a baby boomer, were a drug user or partook in other risky behaviors," Parikh says. "Or ask to have a liver panel drawn if you have one of the diseases to which NAFLD is linked, like obesity or diabetes.

"With better recognition of chronic liver disease, we can prevent these liver cancer numbers from further increasing."

To make an appointment with Michigan Medicine's liver clinic, call 844-233-0433.


More Articles About:

Digestive Health Liver Cancer Cirrhosis of the Liver Nonalcoholic fatty liver disease (NAFLD) Liver Disease Cancer: Cancer Types
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

purple yellow red cells up close
Health Lab

Study explains how colorectal cancer cells maintain high iron levels

How colorectal cancer cells maintain high iron levels, according to Michigan Medicine research.
yellow black purple red cell in middle mostly black
Health Lab

Study sheds light on how early pancreas lesions become cancerous

Why many precursor lesions never develop into pancreatic cancer, according to findings from Michigan Medicine.
couple smiling at michigan game
Health Lab

Alcohol-Related Liver Disease clinic gives patient new hope

Diagnosed with alcohol-related liver cirrhosis, Jennifer Strohpaul decided it was time for a fresh start with the University of Michigan Health Alcohol Related Liver Disease Clinic. Receiving her liver transplant has inspired her to go back to school for her Master’s of Social Work to help patients like herself.
particles forming colorful in intestines
Health Lab

IBS treatment response predicted by gut microbiome in new study

A Michigan Medicine study finds the low FODMAP diet and the antibiotic rifaximin provided similar and significant relief for patients with irritable bowel syndrome with diarrhea (IBS-D).
Triplet babies in a hospital crib
Health Lab

Rare infant triplet overcomes one-in-a-million type of liver cancer

Josephine “JoJo” Wells, a spontaneous triplet, was diagnosed with rare hepatoblastoma at nine months old and treated with surgery and chemotherapy.
Zhen Xu, Ph.D.
News Release

Xu named among Time magazine’s most influential in health

U-M Health Rogel Cancer Center research member Zhen Xu, Ph.D., was selected to Time magazine’s TIME100 Health.